CD4+ and CD8+ T cell expansions using selected TCR V and J gene segments at the onset of giant cell arteritis.

OBJECTIVE To investigate T cell receptor (TCR) V alpha/V beta (and in selected cases, J beta) usage in CD4+ and CD8+ peripheral blood lymphocytes of patients with giant cell arteritis (GCA), before and after treatment, as well as to analyze the HLA types of these patients. METHODS Flow cytometry, with 10 anti-TCR V-specific monoclonal antibodies (MAb), was used. To analyze J beta usage by cell populations expressing certain V beta, we used the polymerase chain reaction (PCR) technique, with V beta- and C beta-specific primers, Southern blotting of PCR products, and subsequent hybridization with radiolabeled J beta-specific probes. HLA typing was performed using the microlymphocytotoxicity technique. RESULTS Seven of the 9 GCA patients had increased anti-TCR V MAb reactivities (interpreted as T cell expansions), which in many cases, correlated with clinical signs of disease. A strict preference for particular J beta segments was found in 3 of 3 expanded CD4+ T cell populations. CONCLUSION T lymphocytes expressing specific antigen receptors are implicated in the pathogenesis of GCA.

[1]  J. Grunewald,et al.  Nonrandom T-cell receptor J beta usage pattern in human CD4+ and CD8+ peripheral T cells. , 1994, Human immunology.

[2]  G. Kroemer,et al.  Glucocorticoid-mediated control of the activation and clonal deletion of peripheral T cells in vivo , 1993, The Journal of experimental medicine.

[3]  S. Stemme,et al.  T lymphocytes in giant cell arteritic lesions are polyclonal cells expressing αβ type antigen receptors and VLA‐1 integrin receptors , 1993 .

[4]  Bernard Malissen,et al.  Characterization of T cell repertoire changes in acute Kawasaki disease , 1993, The Journal of experimental medicine.

[5]  G. Hunder,et al.  The HLA-DRB1 locus as a genetic component in giant cell arteritis. Mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule. , 1992, The Journal of clinical investigation.

[6]  J. Grunewald,et al.  Analysis of Jβ gene segment usage by CD4+ and CD8+ human peripheral blood T lymphocytes , 1992 .

[7]  O. Olerup,et al.  HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. , 1992, Tissue antigens.

[8]  T. Kohsaka,et al.  Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. Grunewald,et al.  Restricted Vα2.3 gene usage by CD4+ T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients correlates with HLA‐DR3 , 1992, European journal of immunology.

[10]  R. Andersson.  Immunological studies in giant cell arteritis. , 1991, Bailliere's clinical rheumatology.

[11]  H. Band,et al.  Increased frequency of T cell receptor V alpha 12.1 expression on CD8+ T cells: evidence that V alpha participates in shaping the peripheral T cell repertoire [published erratum appears in J Exp Med 1991 Nov 1;174(5):following 1286] , 1991, The Journal of experimental medicine.

[12]  J. Grunewald,et al.  Abnormal T‐Cell Expansion and V‐Gene Usage in Myasthenia Gravis Patients , 1991 .

[13]  J. Hillert,et al.  HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. , 1991, Tissue antigens.

[14]  A. Ben-nun,et al.  Evidence of limited variability of antigen receptors on intrathyroidal T cells in autoimmune thyroid disease. , 1991, The New England journal of medicine.

[15]  P. Marrack,et al.  Evidence for the effects of a superantigen in rheumatoid arthritis. , 1991, Science.

[16]  G. Majumdar,et al.  T cell receptor V gene usage by human T cells stimulated with the superantigen streptococcal M protein , 1991, The Journal of experimental medicine.

[17]  M. Crow,et al.  A potential role for microbial superantigens in the pathogenesis of systemic autoimmune disease. , 1991, Arthritis and rheumatism.

[18]  J. Grunewald,et al.  Biased expression of individual T cell receptor V gene segments in CD4+ and CD8+ human peripheral blood T lymphocytes , 1991, European journal of immunology.

[19]  D A Bloch,et al.  The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. , 2010, Arthritis and rheumatism.

[20]  P. Marrack,et al.  Selective expansion of T cells expressing V beta 2 in toxic shock syndrome , 1990, The Journal of experimental medicine.

[21]  A. August,et al.  T cell antigen receptor V gene usage. Increases in V beta 8+ T cells in Crohn's disease. , 1990, The Journal of clinical investigation.

[22]  E. Campo,et al.  IMMUNOHISTOCHEMICAL ANALYSIS OF LYMPHOID AND MACROPHAGE CELL SUBSETS AND THEIR IMMUNOLOGIC ACTIVATION MARKERS IN TEMPORAL ARTERITIS: Influence of Corticosteroid Treatment , 1989, Arthritis and rheumatism.

[23]  R. Jonsson,et al.  HLA-DR expression in the vascular lesion and circulating T lymphocytes of patients with giant cell arteritis. , 1988, Clinical and experimental immunology.

[24]  R. Jonsson,et al.  T cell subsets and expression of immunological activation markers in the arterial walls of patients with giant cell arteritis. , 1987, Annals of the rheumatic diseases.

[25]  E. Thorsby,et al.  HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation--a fast and reliable technique. , 2008, Tissue antigens.

[26]  G. Hunder,et al.  Immunohistologic and cytochemical studies of temporal arteritis. , 1983, Arthritis and rheumatism.

[27]  B. Bengtsson,et al.  The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications. , 1981, Arthritis and rheumatism.